News
Mersana launches anti-cancer drug trial
June 23, 2010 4:38 pm | by Mass High Tech: The Journal of New England Technology | CommentsMersana Therapeutics Inc. has begun a Phase 1 trial of its anti-cancer drug candidate, designed to assess its safety and absorption in the body for patients with advanced solid tumors.
Cloud computing finds its niche in biotech and pharma
June 23, 2010 4:37 pm | by Mass High Tech: The Journal of New England Technology | CommentsThere are big savings in time and money for biotechs and pharmaceutical companies that turn to cloud computing, but it may only be for a while, not necessarily for the long term.
Boston Scientific sets up new $3B credit line
June 23, 2010 4:37 pm | by Mass High Tech: The Journal of New England Technology | CommentsMedical device titan Boston Scientific Corp. has pulled together two deals worth $3 billion combined in loans and credit to replace its existing $1.75 billion revolving credit facility and pay some upcoming notes.
Manufacturer Charged Up About Device to Ease Arthritic Pain
June 23, 2010 4:37 pm | by San Diego Business Journal | CommentsBesides losing weight, receiving cortisone shots, taking pain pills, or getting a total knee replacement, few options exist for patients living with moderate to severe osteoarthritis.
Risk factors for venous thromboembolism and pulmonary embolism differ between races
June 23, 2010 4:35 pm | by EurekAlert | Comments(Wiley-Blackwell) A new study of 1,960 white Americans and 368 black Americans with objectively diagnosed venous thromboembolism showed that, compared to whites, blacks had a significantly higher proportion with pulmonary embolism, including idiopathic PE among black women, and a...
Robert Langer's reach touches New England biotech scene
June 23, 2010 4:34 pm | by Mass High Tech: The Journal of New England Technology | CommentsIt's hard to talk to someone who knows MIT inventor, scientist, professor, humanitarian and entrepreneur Bob Langer without bumping into superlatives. Langer's resume parallels that of the biotechnology industry itself.
Veteran and first-time biotech CEOs find commonalities
June 23, 2010 4:34 pm | by Mass High Tech: The Journal of New England Technology | CommentsBiotech CEOs can learn from each other, but when Aura Biosciences founder and CEO Elisabet de los Pinos sought advice from On-Q-ity CEO Mara Aspinall, it turned out that they had plenty in common with their philosophies and goals.
Lexington biotech febit to cut 60 percent of workforce
June 23, 2010 4:34 pm | by Mass High Tech: The Journal of New England Technology | CommentsDNA analysis technology firm febit Inc. has announced plans to cut its workforce by about 60 percent. The company, which has locations in Lexington and Germany, has a staff of 90 to 100, according to a febit press contact, which would mean up to 60 positions would be sliced from the workforce.
NxStage Medical signs supply contract
June 23, 2010 11:45 am | by The Associated Press | CommentsDialysis products maker NxStage Medical Inc. said Wednesday its Medisystems division has been awarded an exclusive five-year blood tubing supply contract with Atlantic Dialysis Management Services.Terms of the contract were not disclosed.Under the deal, Atlantic Dialysis will now use...
How likely is misdiagnosis?
June 23, 2010 11:32 am | by EurekAlert | Comments(University of Leicester) How likely is misdiagnosis? A researcher at hte University of Leicester is evaluating the accuracy of patient diagnoses.
Report: A few insurers control Medicare Advantage
June 23, 2010 10:45 am | by The Associated Press | CommentsA small number of insurers controls a big chunk of the market for Medicare Advantage health plans, according to a new Kaiser Family Foundation report.The nonprofit foundation said three or fewer companies dominate the market in every state except New York for the plans, which are privately run...
City passes phone radiation law
June 23, 2010 10:37 am | by BBC | CommentsSan Francisco is set to be the first US city to require mobile phone retailers to post radiation levels next to handsets they sell.
Stryker names Roch Doliveux to board
June 23, 2010 9:45 am | by The Associated Press | CommentsMedical device maker Stryker Corp. said Wednesday it named Dr. Roch Doliveux to its board of directors.Doliveux has been CEO of biotechnology company UCB S.A. since 2005. His appointment expands Stryker's board to nine directors.Shares of Stryker fell 6 cents to $50.88 in midday trading.
Everlight, Epistar and TPV to form LED packaging joint venture
June 23, 2010 9:38 am | by I-Micronews | CommentsEverlight Electronics, Epistar, and TPV Technology will establish a joint venture for LED chip packaging and LED light strip production in Fuzhou City in China's Fujian Province, according to the companies. TPV is a dominant LCD TV maker.
Study demonstrates pine bark naturally reduces hay fever symptoms
June 23, 2010 9:36 am | by EurekAlert | Comments(MWW Group) An estimated 60 million people in the US are affected by allergic rhinitis, commonly known as hay fever, according to the American Academy of Allergy Asthma and Immunology. A study published in the June 14, 2010, issue of Phytotherapy Research demonstrates Pycnogenol,...
